HiTT on tour

health & around thoughts, on the fly & on the flight

Drugs in the graveyard increase costs

This week we learned that Merck & Co. was ending the Phase III APECS study of Verubecestat (formerly known as MK-8931) for the treatment of prodromal Alzheimer Disease. Yet another drug in AD graveyard!!

read more

Apps in Africa? Yes, but…

Sometimes, when we think about a new app or technology that will be useful for improving health in African people, we don’t consider the applicability that this app will have.

read more